Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials: A Systematic Review.

Rahib L, Fleshman JM, Matrisian LM, Berlin JD.

JAMA Oncol. 2016 Sep 1;2(9):1209-16. doi: 10.1001/jamaoncol.2016.0585. Review.

PMID:
27270617
2.

Inaugural Meeting of North American Pancreatic Cancer Organizations: Advancing Collaboration and Communication.

Kenner BJ, Fleshman JM, Goldberg AE, Rothschild LJ.

Pancreas. 2015 Nov;44(8):1178-84. doi: 10.1097/MPA.0000000000000549.

3.

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM.

Cancer Res. 2014 Jun 1;74(11):2913-21. doi: 10.1158/0008-5472.CAN-14-0155. Erratum in: Cancer Res. 2014 Jul 15;74(14):4006.

4.

Pancreatic cancer clinical trials and accrual in the United States.

Hoos WA, James PM, Rahib L, Talley AW, Fleshman JM, Matrisian LM.

J Clin Oncol. 2013 Sep 20;31(27):3432-8. doi: 10.1200/JCO.2013.49.4823. Epub 2013 Aug 19.

PMID:
23960185
5.

Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001.

Redston M, Compton CC, Miedema BW, Niedzwiecki D, Dowell JM, Jewell SD, Fleshman JM, Bem J, Mayer RJ, Bertagnolli MM; Leukemia Group B Trial 80001.

J Clin Oncol. 2006 Feb 20;24(6):878-83. Epub 2006 Jan 17.

PMID:
16418493

Supplemental Content

Loading ...
Support Center